Showing results (221-230 of 294) with videos related to

Sort By:
Pageof 30
BMC Nephrology|October 5, 2018
Long-term survival in Japanese renal transplant recipients with Alport syndrome: a retrospective studyAi Katsuma, Yasuyuki Nakada, Izumi Yamamoto, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 22, 2009
Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapyHayato Nishida, Hideki Ishida, Toshiaki Tanaka, et al.
Japanese Journal of Clinical Oncology|April 19, 2020
Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancerTakashi Ikeda, Hiroki Ishihara, Junpei Iizuka, et al.
Annals of Transplantation|June 24, 2017
Cystatin C-Based Equation Does Not Accurately Estimate the Glomerular Filtration in Japanese Living Kidney DonorsKazuma Tsujimura, Morihito Ota, Kiyoshi Chinen, et al.
International Journal of Clinical Oncology|December 21, 2019
Comparable efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinomaHiroki Ishihara, Toshio Takagi, Tsunenori Kondo, et al.
International Journal of Clinical Oncology|February 6, 2026
Clinical evaluation of medical and surgical complete responses in metastatic renal cell carcinoma treated with immune checkpoint inhibitor combination therapyKazuhiko Yoshida, Tsunenori Kondo, Junpei Iizuka, et al.
Japanese Journal of Clinical Oncology|December 16, 2020
Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world dataHiroki Ishihara, Toshio Takagi, Tsunenori Kondo, et al.
Urologic Oncology|March 9, 2020
Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy eraToshio Takagi, Hironori Fukuda, Hiroki Ishihara, et al.
Targeted Oncology|July 31, 2019
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell CarcinomaHiroki Ishihara, Hidekazu Tachibana, Toshio Takagi, et al.
Japanese Journal of Clinical Oncology|February 9, 2021
Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombusShun Watanabe, Hiroki Ishihara, Toshio Takagi, et al.
Pageof 30